ScholarIQanswers from OpenAlex & ORCID
Mithat Gönen
ResearcherPublications, citations & collaboration network
Mithat Gönen is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Mithat Gönen have?
ScholarIQindexed works
Mithat Gönen has 1,348 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mithat Gönen have?
ScholarIQcitation count
Mithat Gönen has 104,350 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Mithat Gönen?
ScholarIQh-index
Mithat Gönen has an h-index of 158 in OpenAlex.
What is the i10-index of Mithat Gönen?
ScholarIQi10-index
Mithat Gönen has an i10-index of 689 in OpenAlex.
What is the ORCID of Mithat Gönen?
ScholarIQorcid
The ORCID for Mithat Gönen is on the source record.
What is the OpenAlex record for Mithat Gönen?
ScholarIQopenalex
The OpenAlex for Mithat Gönen is on the source record.
What are the most-cited papers on Mithat Gönen?
ScholarIQmost cited works
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Marco L. Davila, Isabelle Rivière, Xiuyan Wang, Shirley Bartido, Jae H. Park, Kevin J. Curran, Stephen S. Chung, Jolanta Stefanski, Oriana Bórquez-Ojeda, Malgorzata Olszewska, Jinrong Qu, Teresa Wasielewska, Qing He, Mitsú J. Fink, Himaly Shinglot, Maher Youssif, Mark Satter, Yongzeng Wang, James Hosey, Hilda Quintanilla, Elizabeth Halton, Yvette Bernal, Diana Bouhassira, Maria E. Arcila, Mithat Gönen, Gail J. Roboz, P. Maslak, Dan Douer, Mark G. Frattini, Sergio Giralt, Michel Sadelain, Renier J. Brentjens
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
Bastien Nguyen, Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar, Henry Walch, Walid K. Chatila, Ramyasree Madupuri, Ritika Kundra, Craig M. Bielski, Brooke Mastrogiacomo, Mark T.A. Donoghue, Adrienne Boire, Sarat Chandarlapaty, Karuna Ganesh, James J. Harding, Christine A. Iacobuzio–Donahue, Pedram Razavi, Ed Reznik, Charles M. Rudin, Dmitriy Zamarin, Wassim Abida, Ghassan K. Abou‐Alfa, Carol Aghajanian, Andrea Cercek, Ping Chi, Darren R. Feldman, Alan L. Ho, Gopa Iyer, Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Andrea Cercek, Campbell S.D. Roxburgh, Paul Strombom, J. Joshua Smith, Larissa K. Temple, Garrett M. Nash, José G. Guillem, Philip B. Paty, Rona Yaeger, Zsofia K. Stadler, Kenneth Seier, Mithat Gönen, Neil H. Segal, Diane Reidy‐Lagunes, Anna M. Varghese, Jinru Shia, Efsevia Vakiani, Abraham J. Wu, Christopher H. Crane, Marc J. Gollub, Julio García‐Aguilar, Leonard B. Saltz, Martin R. Weiser
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy
J. Joshua Smith, Paul Strombom, Oliver S. Chow, Campbell S.D. Roxburgh, Patricio B. Lynn, Anne Eaton, Maria Widmar, Karuna Ganesh, Rona Yaeger, Andrea Cercek, Martin R. Weiser, Garrett M. Nash, José G. Guillem, Larissa K. Temple, Sree B. Chalasani, James L. Fuqua, Iva Petkovska, Abraham J. Wu, Marsha Reyngold, Efsevia Vakiani, Jinru Shia, Neil H. Segal, James D. Smith, Christopher H. Crane, Marc J. Gollub, Mithat Gönen, Leonard B. Saltz, Julio García‐Aguilar, Philip B. Paty
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab
Prasad S. Adusumilli, Marjorie G. Zauderer, Isabelle Rivière, Stephen B. Solomon, Valerie W. Rusch, Roisin E. O’Cearbhaill, Amy Zhu, Waseem Cheema, Navin K. Chintala, Elizabeth Halton, John Pineda, Rocío Pérez-Johnston, Kay See Tan, Bobby Daly, Jose A. Araujo Filho, Daniel Ngai, Erin McGee, A. Vincent, Claudia Diamonte, Jennifer L. Sauter, Shanu Modi, Devanjan Sikder, Brigitte Sénéchal, Xiuyan Wang, William D. Travis, Mithat Gönen, Charles M. Rudin, Renier J. Brentjens, David R. Jones, Michel Sadelain